Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Basal cell carcinoma, Plantar pits, Papule, and Macrocephaly; and common findings: Neurofibroma, Nevus, Angiofibromas, and Vertigo and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 3 | Migraine, Calcification of falx cerebri, Hydrocephalus |
SUFU function has not been fully characterized.
Basal cell nevus syndrome 2 is associated with mutations in the SUFU gene on chromosome 10.
Genetic testing for SUFU is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for basal cell nevus syndrome 2 has been reported in the published literature.
Phenotype severity distribution: 4 always present features, 11 common features.
No clinical trials have been registered for basal cell nevus syndrome 2.
22 publications have been identified in PubMed for basal cell nevus syndrome 2. Research spans Epidemiology / Natural History (27%), Case Report / Case Series (23%), and Review / Meta-Analysis (18%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 6 | 27% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:45 AM UTC
Online Mendelian Inheritance in Man
Common questions about basal cell nevus syndrome 2
Ears
1 |
Vertigo |
Skin | 1 | Papule |
Head and neck | 1 | Macrocephaly |
Patient case studies
5 |
23% |
Research summaries | 4 | 18% |
Laboratory research | 3 | 14% |
Clinical study results | 2 | 9% |
Testing and diagnosis research | 1 | 5% |
New treatment approaches | 1 | 5% |
Cahn BA (2026). [PMID: 41396574](https://pubmed.ncbi.nlm.nih.gov/41396574/). *J Am Acad Dermatol*. [Review / Meta-Analysis]
Briatico G (2026). [PMID: 40426338](https://pubmed.ncbi.nlm.nih.gov/40426338/). *Int J Dermatol*. [Epidemiology / Natural History]
Yapijakis C (2026). [PMID: 41273553](https://pubmed.ncbi.nlm.nih.gov/41273553/). *Adv Exp Med Biol*. [Case Report / Case Series]
Madhu M (2026). [PMID: 41884741](https://pubmed.ncbi.nlm.nih.gov/41884741/). *Indian J Dermatol*. [Basic Science / Preclinical]
Li JTW (2026). [PMID: 40537330](https://pubmed.ncbi.nlm.nih.gov/40537330/). *Int J Oral Maxillofac Surg*. [Clinical Trial Publication]
Brandtzæg KH (2026). [PMID: 41129277](https://pubmed.ncbi.nlm.nih.gov/41129277/). *Br J Dermatol*. [Epidemiology / Natural History]
Massella Patsea AAL (2026). [PMID: 42178865](https://pubmed.ncbi.nlm.nih.gov/42178865/). *Br J Dermatol*. [Epidemiology / Natural History]
Hideshima I (2025). [PMID: 39581763](https://pubmed.ncbi.nlm.nih.gov/39581763/). *J Oral Pathol Med*. [Gene Therapy / Novel Therapeutics]
Harshe I (2025). [PMID: 39740804](https://pubmed.ncbi.nlm.nih.gov/39740804/). *J Med Genet*. [Review / Meta-Analysis]
Hercent A (2025). [PMID: 38768301](https://pubmed.ncbi.nlm.nih.gov/38768301/). *Clin Exp Dermatol*. [Basic Science / Preclinical]
AI-curated news mentioning basal cell nevus syndrome 2
Updated Aug 11, 2026
A recent study published in PubMed examines the quality of life, mental health, and executive function in individuals with basal cell naevus syndrome. The findings highlight the psychological and cognitive challenges faced by patients, emphasizing the need for comprehensive care strategies.